REGN Regeneron Pharmaceuticals

held by 1 manager in Q3 2017

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.65%	3 mo	NEW	$14M	31,800

Search